The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
The company will offer end-to-end services and solutions for the sector with a specific focus on sustainability
Reported revenue from operations up by 11% to Rs. 944 crores Reported PAT (after exceptional items) up by 18% to Rs. 131 crore
Biocon Biologics remains committed to global standards of quality and compliance
The site’s GMP Certification has been successfully renewed
The cornerstone of the quality ecosystem is the implementation of the Quality Control Orders
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
Exploring new opportunities within the fast-growing market of microfluidics
The inspection scope had included six separate Biologics manufacturing units comprising of four Drug Substance and two Drug Product manufacturing plants
Subscribe To Our Newsletter & Stay Updated
